Login to Your Account



Serono Parkinson's Drug In Phase III

Newron IPO: Up To $289M For CNS Drug Development

By Randall Osborne


Tuesday, November 28, 2006
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription